To develop and market medical devices that bring the remarkable therapeutic benefits of ischemic conditioning to clinical practice and health consumers. IC Therapeutics, Inc. is a portfolio company of Fairway Medical Technologies, Inc. and In3 Ventures, Ltd.
Initial Areas of Focus:
- Athletic training
- Reduce ischemic injury during acute coronary and cerebrovascular events (Heart Attack and Stroke).
Reduce ischemic tissue injury and perioperative complications during cardiac stenting and major surgical procedures.
Improve claudication symptoms in PAD patients (Peripheral Artery Disease).
- Repeated ischemic conditioning to lower blood pressure and improve endothelial / vascular function.